Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Werner

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Expert Opinion on Investigational Drugs|July 5, 2005
Transgenic manufactured biopharmaceuticals: a new method of drug manufacturingR G Werner
Antimicrobial Agents and Chemotherapy|December 1, 1980
Uptake of indolmycin in gram-positive bacteriaR G Werner
Arzneimittel-Forschung|June 3, 1998
Innovative and economic potential of mammalian cell cultureR G Werner
Arzneimittel-Forschung|July 18, 2001
Improving natural principles with genetic engineering: TNK-tissue plasminogen activatorR G Werner
Arzneimittel-Forschung|June 25, 1998
Identification and development of new biopharmaceuticalsR G Werner
Arzneimittel-Forschung|September 1, 1987
Biobusiness in the pharmaceutical industryR G Werner
Klinische Wochenschrift|January 1, 1988
[Biotechnical production of drugs with special reference to tissue-type plasminogen activator]R G Werner
Arzneimittel-Forschung|September 1, 1995
[New horizons for medicine on the basis of genetic technology]R G Werner
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1994
Gene technology: chances for diagnosis and therapyR G Werner
Arzneimittel-Forschung|September 1, 1986
New biotechnology as a logical outgrowth of molecular biologyR G Werner
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|July 5, 2005
Transgenic manufactured biopharmaceuticals: a new method of drug manufacturingR G Werner
Antimicrobial Agents and Chemotherapy|December 1, 1980
Uptake of indolmycin in gram-positive bacteriaR G Werner
Arzneimittel-Forschung|June 3, 1998
Innovative and economic potential of mammalian cell cultureR G Werner
Arzneimittel-Forschung|July 18, 2001
Improving natural principles with genetic engineering: TNK-tissue plasminogen activatorR G Werner
Arzneimittel-Forschung|June 25, 1998
Identification and development of new biopharmaceuticalsR G Werner
Arzneimittel-Forschung|September 1, 1987
Biobusiness in the pharmaceutical industryR G Werner
Klinische Wochenschrift|January 1, 1988
[Biotechnical production of drugs with special reference to tissue-type plasminogen activator]R G Werner
Arzneimittel-Forschung|September 1, 1995
[New horizons for medicine on the basis of genetic technology]R G Werner
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1994
Gene technology: chances for diagnosis and therapyR G Werner
Arzneimittel-Forschung|September 1, 1986
New biotechnology as a logical outgrowth of molecular biologyR G Werner
Pageof 5